{"id":"https://openalex.org/W1919624826","doi":"https://doi.org/10.1200/jco.1997.15.5.2125","title":"Carboxypeptidase-G2, thymidine, and leucovorin rescue in cancer patients with methotrexate-induced renal dysfunction.","display_name":"Carboxypeptidase-G2, thymidine, and leucovorin rescue in cancer patients with methotrexate-induced renal dysfunction.","publication_year":1997,"publication_date":"1997-05-01","ids":{"openalex":"https://openalex.org/W1919624826","doi":"https://doi.org/10.1200/jco.1997.15.5.2125","mag":"1919624826","pmid":"https://pubmed.ncbi.nlm.nih.gov/9164227"},"language":"en","primary_location":{"id":"doi:10.1200/jco.1997.15.5.2125","doi":"https://doi.org/10.1200/jco.1997.15.5.2125","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.1997.15.5.2125","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5071679104","display_name":"Brigitte C. Widemann","orcid":"https://orcid.org/0000-0002-9198-7175","observed_orcids":["https://orcid.org/0000-0002-9198-7175"]},"institutions":[{"id":"https://openalex.org/I1299303238","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238"]},{"id":"https://openalex.org/I4210140884","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210140884"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"B C Widemann","raw_affiliation_strings":["Pediatric Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892-1928, USA. widemanb@pbmac.nci.nih.gov"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pediatric Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892-1928, USA. widemanb@pbmac.nci.nih.gov","institution_ids":["https://openalex.org/I1299303238","https://openalex.org/I4210140884"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5024249524","display_name":"Frank M. Balis","orcid":"https://orcid.org/0000-0002-8117-6926","observed_orcids":["https://orcid.org/0000-0002-8117-6926"]},"institutions":[{"id":"https://openalex.org/I1299303238","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"F M Balis","raw_affiliation_strings":["National Institutes of Health"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"National Institutes of Health","institution_ids":["https://openalex.org/I1299303238"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103444653","display_name":"Robert F. Murphy","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1299303238","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"R F Murphy","raw_affiliation_strings":["National Institutes of Health"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"National Institutes of Health","institution_ids":["https://openalex.org/I1299303238"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5028595129","display_name":"John M. Sorensen","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1299303238","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"J M Sorensen","raw_affiliation_strings":["National Institutes of Health"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"National Institutes of Health","institution_ids":["https://openalex.org/I1299303238"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5087392629","display_name":"Michael J. Montello","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1299303238","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"M J Montello","raw_affiliation_strings":["National Institutes of Health"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"National Institutes of Health","institution_ids":["https://openalex.org/I1299303238"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5008879971","display_name":"Michelle O'Brien","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1299303238","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"M O'Brien","raw_affiliation_strings":["National Institutes of Health"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"National Institutes of Health","institution_ids":["https://openalex.org/I1299303238"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5066484657","display_name":"Peter C. Adamson","orcid":"https://orcid.org/0000-0002-9487-757X","observed_orcids":["https://orcid.org/0000-0002-9487-757X"]},"institutions":[{"id":"https://openalex.org/I1299303238","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"P C Adamson","raw_affiliation_strings":["National Institutes of Health"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"National Institutes of Health","institution_ids":["https://openalex.org/I1299303238"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":3.399,"has_fulltext":false,"cited_by_count":127,"citation_normalized_percentile":{"value":0.91821445,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":88,"max":99},"biblio":{"volume":"15","issue":"5","first_page":"2125","last_page":"2134"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T12429","display_name":"Chemotherapy-induced organ toxicity mitigation","score":0.9883000254631042,"subfield":{"id":"https://openalex.org/subfields/2734","display_name":"Pathology and Forensic Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T12429","display_name":"Chemotherapy-induced organ toxicity mitigation","score":0.9883000254631042,"subfield":{"id":"https://openalex.org/subfields/2734","display_name":"Pathology and Forensic Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10684","display_name":"Acute Kidney Injury Research","score":0.003100000089034438,"subfield":{"id":"https://openalex.org/subfields/2727","display_name":"Nephrology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12845","display_name":"Methemoglobinemia and Tumor Lysis Syndrome","score":0.0017999999690800905,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/carboxypeptidase-g2","display_name":"carboxypeptidase G2","score":0.9240000247955322},{"id":"https://openalex.org/keywords/methotrexate-nephrotoxicity","display_name":"methotrexate nephrotoxicity","score":0.9950000047683716},{"id":"https://openalex.org/keywords/thymidine","display_name":"thymidine","score":0.9049999713897705},{"id":"https://openalex.org/keywords/leucovorin","display_name":"leucovorin","score":0.9470000267028809},{"id":"https://openalex.org/keywords/high-dose-methotrexate","display_name":"high-dose methotrexate","score":0.8619999885559082},{"id":"https://openalex.org/keywords/osteosarcoma","display_name":"osteosarcoma","score":0.8050000071525574},{"id":"https://openalex.org/keywords/lymphoid-malignancies","display_name":"lymphoid malignancies","score":0.7390000224113464},{"id":"https://openalex.org/keywords/gastric-cancer","display_name":"gastric cancer","score":0.8059999942779541},{"id":"https://openalex.org/keywords/renal-dysfunction","display_name":"renal dysfunction","score":0.675000011920929},{"id":"https://openalex.org/keywords/expanded-access","display_name":"compassionate use","score":0.5049999952316284}],"concepts":[{"id":"https://openalex.org/C2781059491","wikidata":"https://www.wikidata.org/wiki/Q422232","display_name":"Methotrexate","level":2,"score":0.8835971355438232},{"id":"https://openalex.org/C126189478","wikidata":"https://www.wikidata.org/wiki/Q1468324","display_name":"Nephrotoxicity","level":3,"score":0.8387262225151062},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.761603593826294},{"id":"https://openalex.org/C2780306776","wikidata":"https://www.wikidata.org/wiki/Q426660","display_name":"Creatinine","level":2,"score":0.6068241000175476},{"id":"https://openalex.org/C29730261","wikidata":"https://www.wikidata.org/wiki/Q274160","display_name":"Toxicity","level":2,"score":0.5540138483047485},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.5194277763366699},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.5181556940078735},{"id":"https://openalex.org/C159641895","wikidata":"https://www.wikidata.org/wiki/Q108377937","display_name":"Renal function","level":2,"score":0.508882999420166},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.44419533014297485},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.429510235786438}],"mesh":[{"descriptor_ui":"D000293","descriptor_name":"Adolescent","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000931","descriptor_name":"Antidotes","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D000964","descriptor_name":"Antimetabolites, Antineoplastic","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D000964","descriptor_name":"Antimetabolites, Antineoplastic","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D000964","descriptor_name":"Antimetabolites, Antineoplastic","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D002268","descriptor_name":"Carboxypeptidases","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D002268","descriptor_name":"Carboxypeptidases","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D002648","descriptor_name":"Child","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002675","descriptor_name":"Child, Preschool","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002955","descriptor_name":"Leucovorin","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007223","descriptor_name":"Infant","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007668","descriptor_name":"Kidney","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D007668","descriptor_name":"Kidney","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D007674","descriptor_name":"Kidney Diseases","qualifier_ui":"Q000139","qualifier_name":"chemically induced","is_major_topic":true},{"descriptor_ui":"D007674","descriptor_name":"Kidney Diseases","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D007674","descriptor_name":"Kidney Diseases","qualifier_ui":"Q000517","qualifier_name":"prevention & control","is_major_topic":false},{"descriptor_ui":"D008228","descriptor_name":"Lymphoma, Non-Hodgkin","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D008228","descriptor_name":"Lymphoma, Non-Hodgkin","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008727","descriptor_name":"Methotrexate","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D008727","descriptor_name":"Methotrexate","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D008727","descriptor_name":"Methotrexate","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012509","descriptor_name":"Sarcoma","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D012509","descriptor_name":"Sarcoma","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D013936","descriptor_name":"Thymidine","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D013936","descriptor_name":"Thymidine","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D054198","descriptor_name":"Precursor Cell Lymphoblastic Leukemia-Lymphoma","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D054198","descriptor_name":"Precursor Cell Lymphoblastic Leukemia-Lymphoma","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1200/jco.1997.15.5.2125","doi":"https://doi.org/10.1200/jco.1997.15.5.2125","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.1997.15.5.2125","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"},{"id":"pmid:9164227","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/9164227","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of clinical oncology : official journal of the American Society of Clinical Oncology","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":1.0}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":26,"referenced_works":["https://openalex.org/W193327553","https://openalex.org/W1523914333","https://openalex.org/W1527643427","https://openalex.org/W1558085296","https://openalex.org/W1644060166","https://openalex.org/W1873638046","https://openalex.org/W1887694034","https://openalex.org/W1909222477","https://openalex.org/W1956830062","https://openalex.org/W1971035689","https://openalex.org/W1985700452","https://openalex.org/W1995376945","https://openalex.org/W2011847171","https://openalex.org/W2012016485","https://openalex.org/W2019594191","https://openalex.org/W2022602421","https://openalex.org/W2038530467","https://openalex.org/W2063839422","https://openalex.org/W2064073569","https://openalex.org/W2066426933","https://openalex.org/W2079184776","https://openalex.org/W2080948320","https://openalex.org/W2082251186","https://openalex.org/W2130705999","https://openalex.org/W2396745929","https://openalex.org/W2418246579"],"related_works":["https://openalex.org/W2066426933","https://openalex.org/W2339510383","https://openalex.org/W1877965418","https://openalex.org/W2007595730","https://openalex.org/W2083419011","https://openalex.org/W2189191441","https://openalex.org/W2124815378","https://openalex.org/W2088462270","https://openalex.org/W2318172114","https://openalex.org/W2145576587"],"abstract_inverted_index":{"PURPOSE:":[0],"Methotrexate":[1],"nephrotoxicity":[2,53,175,256],"can":[3],"lead":[4],"to":[5,38,89,205,217,222],"delayed":[6,258],"methotrexate":[7,37,57,116,142,157,184,211,249,259],"elimination":[8],"and":[9,63,72,107,117,127,138,144,168,181,193,199,234,257],"the":[10,21,44,209,252],"development":[11,140],"of":[12,47,66,92,115,136,141,146,228,254],"life-threatening":[13,248],"toxicity,":[14],"which":[15],"may":[16],"not":[17],"be":[18],"preventable":[19],"with":[20,70,82],"standard":[22,108],"rescue":[23,68,195,236],"agent":[24],"leucovorin.":[25],"In":[26],"preclinical":[27],"studies,":[28],"we":[29],"previously":[30],"demonstrated":[31],"that":[32],"carboxypetidase-G2":[33],"(CPDG2)":[34],"rapidly":[35],"hydrolyzes":[36],"nontoxic":[39],"metabolites.":[40],"A":[41],"protocol":[42],"for":[43,158,246],"compassionate":[45],"use":[46],"CPDG2":[48,67,129,137,192],"in":[49,74,201,208,240],"patients":[50,76,153,242],"who":[51,154],"develop":[52],"while":[54],"receiving":[55],"high-dose":[56,83,156],"was":[58,196,215,237],"therefore":[59],"developed.":[60],"The":[61],"pharmacologic":[62],"clinical":[64],"outcome":[65],"administered":[69],"thymidine":[71,100,194],"leucovorin":[73,111,235],"20":[75,241],"is":[77],"presented":[78],"here.":[79],"METHODS:":[80],"Patients":[81],"methotrexate-induced":[84,255],"renal":[85,147],"dysfunction":[86],"received":[87,155],"one":[88],"three":[90],"doses":[91],"CPDG2,":[93,232],"50":[94],"U/kg":[95],"body":[96],"weight":[97],"intravenously":[98],"(i.v.),":[99],"8":[101],"g/m2/d":[102],"by":[103],"continuous":[104],"i.v.":[105],"infusion,":[106],"pharmacokinetically":[109],"guided":[110],"rescue.":[112],"Plasma":[113],"concentrations":[114,185],"its":[118],"inactive":[119],"metabolite":[120],"4-deoxy-4-amino-N10-methylpteroic":[121],"acid":[122],"(DAMPA)":[123],"were":[124,149],"measured":[125],"before":[126],"after":[128,251],"using":[130],"high-pressure":[131],"liquid":[132],"chromatography":[133],"(HPLC).":[134],"Tolerance":[135],"thymidine,":[139,233],"toxicities,":[143],"recovery":[145],"function":[148],"monitored.":[150],"RESULTS:":[151],"Twenty":[152],"osteosarcoma":[159],"(n":[160,165,171],"=":[161,166,172],"11),":[162],"lymphoid":[163],"cancers":[164],"8),":[167],"gastric":[169],"cancer":[170],"1)":[173],"developed":[174],"(median":[176],"serum":[177],"creatinine,":[178],"3.2":[179],"mg/dL)":[180],"elevated":[182],"plasma":[183,210],"(median,":[186],"201":[187],"mumol/L":[188],"at":[189,225,243],"hour":[190],"46).":[191],"well":[197],"tolerated":[198],"resulted":[200],"a":[202,226],"rapid":[203],"95.6%":[204],"99.6%":[206],"reduction":[207],"concentration.":[212],"Methotrexate-related":[213],"toxicity":[214,250],"mild":[216],"moderate.":[218],"Serum":[219],"creatinine":[220],"returned":[221],"normal":[223],"values":[224],"median":[227],"22":[229],"days.":[230],"CONCLUSION:":[231],"highly":[238],"effective":[239],"high":[244],"risk":[245],"developing":[247],"onset":[253],"excretion.":[260]},"counts_by_year":[{"year":2026,"cited_by_count":2},{"year":2025,"cited_by_count":3},{"year":2024,"cited_by_count":4},{"year":2023,"cited_by_count":4},{"year":2022,"cited_by_count":6},{"year":2021,"cited_by_count":5},{"year":2020,"cited_by_count":1},{"year":2019,"cited_by_count":5},{"year":2018,"cited_by_count":2},{"year":2017,"cited_by_count":5},{"year":2016,"cited_by_count":4},{"year":2015,"cited_by_count":5},{"year":2014,"cited_by_count":1},{"year":2013,"cited_by_count":6},{"year":2012,"cited_by_count":10}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}